Total planned funding: $174,600,654
Allocations
Countries/Regions
Ukraine | $174,600,654 |
Organizational Types
Unknown | $53,821,495 |
NGO | $38,306,211 |
Private Contractor | $22,696,695 |
Own Agency | $22,684,469 |
Multi-lateral Agency | $12,489,021 |
University | $9,827,000 |
Implementing Agency | $6,825,040 |
Other USG Agency | $6,100,723 |
Host Country Government Agency | $1,850,000 |
Program Areas
Governance and Systems | $76,851,000 |
Treatment | $24,500,075 |
Prevention | $22,114,590 |
Testing | $19,561,750 |
Management and Operations | $16,530,594 |
Care | $15,042,645 |
Budget Codes
OHSS: Health Systems Strengthening | $43,786,054 |
HTXS: Treatment: Adult Treatment | $20,736,080 |
HVCT: Testing: HIV Testing and Counseling | $19,561,750 |
HVSI: Strategic Information | $19,522,431 |
HVMS: Management and Operations | $16,530,594 |
HLAB: Laboratory Infrastructure | $13,542,515 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $11,179,126 |
HVTB: Care: TB/HIV | $8,034,655 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,874,778 |
HBHC: Care: Adult Care and Support | $4,285,356 |
HTXD: Treatment: ARV Drugs | $3,763,995 |
HMBL: Biomedical Prevention: Blood Safety | $3,370,435 |
HKID: Care: Orphans and Vulnerable Children | $2,722,634 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $146,894 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
PDTX: Treatment: Pediatric Treatment | $0 |
Top Partner Programs
Not Available:
$50,051,495
Countries/Regions
USG Aggregated Agencies:
$17,651,733
Countries/Regions
Deloitte Consulting Limited:
$10,625,011
Countries/Regions
Chemonics International:
$10,121,684
Countries/Regions